New CEO Steve Hemsley outlines cost review and Medicare Advantage strategy shift at annual meeting
UnitedHealth Group’s newly reinstated CEO, Steve Hemsley, pledged to rebuild shareholder confidence following the company’s first earnings miss since 2008. Speaking at the company’s annual shareholder meeting on Monday, Hemsley acknowledged recent missteps and committed to reassessing core business practices.
“We are well aware we have not fulfilled your expectations or our own,” Hemsley said. “We apologize for that performance, and we’re humbly determined to earn back your trust and your confidence.”
Hemsley returned to the CEO role in May, replacing Andrew Witty amid mounting pressure following an unexpected earnings shortfall. The miss was driven largely by higher-than-anticipated medical costs in UnitedHealth’s Medicare Advantage business, which provides health coverage for Americans aged 65 and older as well as people with disabilities.
In response, UnitedHealth suspended its earnings outlook and initiated a comprehensive review of its cost assumptions and forecasting models. Hemsley said the company will adjust its private insurance and Medicare Advantage plans to better reflect elevated care expenses.
UnitedHealth, which owns major business units such as health insurer UnitedHealthcare and pharmacy benefit manager Optum Rx, will also examine its operational practices company-wide.
The leadership change and strategic reset come at a critical time for the healthcare giant, as it seeks to reassure investors about its long-term growth trajectory. Hemsley’s remarks signal a more cautious and data-driven approach to risk management, particularly in the rapidly evolving Medicare space.
Investors will now look for clear follow-through as UnitedHealth recalibrates its outlook and cost strategies under Hemsley’s renewed leadership.
You might like this article:Marvell Projects Strong Q2 Growth on AI Chip Demand Surge
